Norcantharidin impairs medulloblastoma growth by inhibition of Wnt/β-catenin signaling.
about
Pediatric medulloblastoma - update on molecular classification driving targeted therapiesNorcantharidin, derivative of cantharidin, for cancer stem cellsAntimetastatic effects of norcantharidin on hepatocellular carcinoma by transcriptional inhibition of MMP-9 through modulation of NF-kB activityIntraarterial administration of norcantharidin attenuates ischemic stroke damage in rodents when given at the time of reperfusion: novel uses of endovascular capabilities.XAV939-mediated ARTD activity inhibition in human MB cell lines.N-Farnesyloxy-norcantharimide inhibits progression of human leukemic Jurkat T cells through regulation of mitogen-activated protein kinase and interleukin-2 production.HDAC and PI3K Antagonists Cooperate to Inhibit Growth of MYC-Driven Medulloblastoma.Evolving molecular era of childhood medulloblastoma: time to revisit therapy.Natural compounds for pediatric cancer treatment.Medulloblastoma: Tumor Biology and Relevance to Treatment and Prognosis Paradigm.Wnt activation affects proliferation, invasiveness and radiosensitivity in medulloblastoma.WNT/β-catenin pathway activation in Myc immortalised cerebellar progenitor cells inhibits neuronal differentiation and generates tumours resembling medulloblastoma.Biflavone Ginkgetin, a Novel Wnt Inhibitor, Suppresses the Growth of Medulloblastoma.Norcantharidin induces growth inhibition and apoptosis of glioma cells by blocking the Raf/MEK/ERK pathway.
P2860
Q21129295-D77B6ED7-3ACB-4CC2-BEDC-9468E4464448Q28388647-887E5DE5-5CA8-4202-B03F-0F63C77689C7Q28480863-5CA76BFE-D45F-4704-B883-906A0DB14003Q30840750-117540D1-E6B9-43BC-B56B-C888975EF8DFQ35593198-A7C64F36-2D66-4204-A4DB-161D7C295BECQ36106828-CA959A5D-2A17-4383-89A4-53BC1F963148Q36694288-E6B62BD6-C981-4D1F-83C8-2E4B21698DA1Q38652681-C1068367-CCCD-4B5C-99C8-EE12FAE64F22Q38663897-2DAD0367-CB7C-4220-AA5B-3F7A4A631D75Q38791824-4448C61D-9CEE-4656-83B8-1345B4C41FC6Q38952766-33369F66-19CF-4F2A-9B72-FCBE099826E0Q39289215-3ED0AF1B-858C-45E0-BF07-E5BB2A168DC4Q39773100-69DFA12B-E9F8-4996-8BA4-0A5727BB512AQ42753890-3A8C91A2-0A68-4C49-BF7C-CC45A537E9EB
P2860
Norcantharidin impairs medulloblastoma growth by inhibition of Wnt/β-catenin signaling.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Norcantharidin impairs medulloblastoma growth by inhibition of Wnt/β-catenin signaling.
@en
Norcantharidin impairs medulloblastoma growth by inhibition of Wnt/β-catenin signaling.
@nl
type
label
Norcantharidin impairs medulloblastoma growth by inhibition of Wnt/β-catenin signaling.
@en
Norcantharidin impairs medulloblastoma growth by inhibition of Wnt/β-catenin signaling.
@nl
prefLabel
Norcantharidin impairs medulloblastoma growth by inhibition of Wnt/β-catenin signaling.
@en
Norcantharidin impairs medulloblastoma growth by inhibition of Wnt/β-catenin signaling.
@nl
P2093
P2860
P1476
Norcantharidin impairs medulloblastoma growth by inhibition of Wnt/β-catenin signaling.
@en
P2093
Flora Cimmino
Gennaro De Vita
Maria Nunzia Scoppettuolo
Marianeve Carotenuto
Massimo Zollo
Pasqualino De Antonellis
Valeria Di Dato
P2860
P2888
P356
10.1007/S11060-011-0645-Y
P577
2011-07-07T00:00:00Z